title: High-dose daunorubicin (DNR) for induction and treatment of relapse in acute promyelocytic leukemia (APL): report of 17 cases.
authors.forename: E
authors.initials: E
authors.lastname: Bobbio Pallavicini
authors.forename: P
authors.initials: P
authors.lastname: Luliri
authors.forename: L
authors.initials: L
authors.lastname: Anselmetti
authors.forename: M
authors.initials: M
authors.lastname: Gorini
authors.forename: R
authors.initials: R
authors.lastname: Invernizzi
authors.forename: E
authors.initials: E
authors.lastname: Ascari
mesh_terms: D000293:Adolescent; D000328:Adult; D003630:Daunorubicin / Q000008:administration & dosage*; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D012008:Recurrence; D012074:Remission Induction
chemical_list: D003630:Daunorubicin